The FIP Foundation for Education and Research has appointed three new Board Directors and reappointed a director to serve another term. All newly appointed directors will resume in office 15 September 2022.
In a statement made available to Pharmanewsonline, announcing their appointment on Wednesday, FIP disclosed that the board directors and representatives support the FIP Foundation in achieving its objective to support the education and research by pharmacists and pharmaceutical scientists.
The three new directors appointed are Dr Jennifer Marriott; Mr Andrew Gray and Prof Rebekah Moles. Their terms will last for two years with a possibility of reappointment. While Meindert Danhof is the board director reappointed to serve an additional two-year term.
Prof. Jenelle Sobotka, chair of the Foundation, said: “The programmes and activities of the Foundation will benefit greatly from the addition of these new and continuing board members who bring both expertise and committed dedication to the work of the Foundation.
“We are delighted to have them join our team of current board members. In addition, I would like to thank both Dr Regis Vallencourt and Prof. Lee Vermeulen for their service on the board, which will conclude in September.“
FIP Foundation for Education and Research was set up in 1993, with the objectives to promote the education of and research by pharmacists and pharmaceutical scientists within the general fields of design, manufacture, distribution and use of medicines for humans and/or animals.
In order to achieve its objectives, the foundation may, among other activities, allocate grants to support education or research and award scholarships to permit short periods of travel in order to study the practice of pharmacy or pharmaceutical science in other countries.
The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists and pharmaceutical scientists, and is in official relations with the World Health Organisation.
Through its 146 member organisations, the apex Pharmacy body represents over four million practitioners and scientists around the world.
